autism spectrum disorder (off-label)
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical indication
|
| gptkbp:commonMedicationsInclude |
gptkb:SSRIs
gptkb:melatonin gptkb:aripiprazole gptkb:risperidone anticonvulsants stimulants |
| https://www.w3.org/2000/01/rdf-schema#label |
autism spectrum disorder (off-label)
|
| gptkbp:mayInclude |
prescription of medications not FDA-approved for autism
|
| gptkbp:regulates |
not FDA-approved for core symptoms of autism
|
| gptkbp:relatedTo |
gptkb:autism_spectrum_disorder
|
| gptkbp:requires |
informed consent
clinical judgment |
| gptkbp:riskFactor |
potential side effects
|
| gptkbp:target |
sleep disturbances
repetitive behaviors irritability hyperactivity |
| gptkbp:usedIn |
off-label drug use
|
| gptkbp:bfsParent |
gptkb:fluvoxamine
|
| gptkbp:bfsLayer |
6
|